Freenome, Inc. (FRNM) stock
FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.82−0.27 (-2.68%)
Close on Nov 17, 2026Market cap $1.09BP/E –Yield –
Freenome operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Freenome's operating cash flow for the twelve months ending Sep 30, 2026 was $82.12M. For fiscal 2025 it was -$864.65K.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$864.65K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$58.27M | – |
| Q2 FY2026 | Jun 30, 2026 | -$129.81K | – |
| Q1 FY2026 | Mar 31, 2026 | -$297.85K | – |
| Q4 FY2025 | Dec 31, 2025 | $140.82M | – |
| Q3 FY2025 | Sep 30, 2025 | -$141.30M | – |
| Q2 FY2025 | Jun 30, 2025 | -$147.53K | – |
| Q1 FY2025 | Mar 31, 2025 | -$237.75K | – |
| Q2 FY2024 | Jun 30, 2024 | -$196.33K | – |
See a number that looks wrong?